Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biote (BTMD) EBIT Margin (2021 - 2025)

Biote has reported EBIT Margin over the past 5 years, most recently at 59.27% for Q4 2025.

  • Quarterly results put EBIT Margin at 59.27% for Q4 2025, up 11672.0% from a year ago — trailing twelve months through Dec 2025 was 29.25% (up 2914.0% YoY), and the annual figure for FY2025 was 62.84%, up 6273.0%.
  • EBIT Margin for Q4 2025 was 59.27% at Biote, up from 17.24% in the prior quarter.
  • Over the last five years, EBIT Margin for BTMD hit a ceiling of 59.27% in Q4 2025 and a floor of 206.98% in Q2 2022.
  • Median EBIT Margin over the past 5 years was 17.57% (2023), compared with a mean of 2.29%.
  • Biggest five-year swings in EBIT Margin: tumbled -23650bps in 2022 and later soared 22254bps in 2023.
  • Biote's EBIT Margin stood at 15.78% in 2021, then rose by 4bps to 16.42% in 2022, then crashed by -409bps to 50.77% in 2023, then fell by -13bps to 57.45% in 2024, then soared by 203bps to 59.27% in 2025.
  • The last three reported values for EBIT Margin were 59.27% (Q4 2025), 17.24% (Q3 2025), and 22.03% (Q2 2025) per Business Quant data.